Theodore J. Criares

Array ( [id] => 4199358 [patent_doc_number] => 06013672 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Agonists of metabotropic glutamate receptors and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/993760 [patent_app_country] => US [patent_app_date] => 1997-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 38 [patent_no_of_words] => 11524 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013672.pdf [firstpage_image] =>[orig_patent_app_number] => 993760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994578 [patent_doc_number] => 05919802 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Methods of preventing and/or treating temporal lobe epilepsy' [patent_app_type] => 1 [patent_app_number] => 8/985766 [patent_app_country] => US [patent_app_date] => 1997-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5584 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919802.pdf [firstpage_image] =>[orig_patent_app_number] => 985766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4295894 [patent_doc_number] => 06197789 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Prevention and treatment of cardiovascular pathologies with tamoxifen analogues' [patent_app_type] => 1 [patent_app_number] => 8/973570 [patent_app_country] => US [patent_app_date] => 1997-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 37165 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197789.pdf [firstpage_image] =>[orig_patent_app_number] => 973570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924701 [patent_doc_number] => 05945412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Methods and compositions for preventing and treating bone loss' [patent_app_type] => 1 [patent_app_number] => 8/984425 [patent_app_country] => US [patent_app_date] => 1997-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12236 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 1058 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945412.pdf [firstpage_image] =>[orig_patent_app_number] => 984425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420737 [patent_doc_number] => 06515016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-04 [patent_title] => 'Composition and methods of paclitaxel for treating psoriasis' [patent_app_type] => B2 [patent_app_number] => 08/980549 [patent_app_country] => US [patent_app_date] => 1997-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 104 [patent_figures_cnt] => 161 [patent_no_of_words] => 56904 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/515/06515016.pdf [firstpage_image] =>[orig_patent_app_number] => 08980549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3987811 [patent_doc_number] => 05985335 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates' [patent_app_type] => 1 [patent_app_number] => 8/875381 [patent_app_country] => US [patent_app_date] => 1997-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2235 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985335.pdf [firstpage_image] =>[orig_patent_app_number] => 875381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048432 [patent_doc_number] => 05869500 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Pyridone compounds useful in treating Alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/976541 [patent_app_country] => US [patent_app_date] => 1997-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10479 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 423 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869500.pdf [firstpage_image] =>[orig_patent_app_number] => 976541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992399 [patent_doc_number] => 05891868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Methods for treating postmenopausal women using ultra-low doses of estrogen' [patent_app_type] => 1 [patent_app_number] => 8/975599 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 14328 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891868.pdf [firstpage_image] =>[orig_patent_app_number] => 975599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3994309 [patent_doc_number] => 05919789 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Xanthines and their therapeutic use' [patent_app_type] => 1 [patent_app_number] => 8/971857 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3552 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919789.pdf [firstpage_image] =>[orig_patent_app_number] => 971857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947412 [patent_doc_number] => 05977181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Therapeutic uses for nitric oxide inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/969475 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13213 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977181.pdf [firstpage_image] =>[orig_patent_app_number] => 969475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934554 [patent_doc_number] => 05929101 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Use of insulin sensitizing agents to treat hypertension' [patent_app_type] => 1 [patent_app_number] => 8/963734 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1546 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929101.pdf [firstpage_image] =>[orig_patent_app_number] => 963734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924313 [patent_doc_number] => 05914346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Methods of treating animals to enhance natural killer lymphocyte function' [patent_app_type] => 1 [patent_app_number] => 8/963740 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2923 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914346.pdf [firstpage_image] =>[orig_patent_app_number] => 963740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834076 [patent_doc_number] => 05814670 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Use of insulin sensitizing agents to treat hypertension' [patent_app_type] => 1 [patent_app_number] => 8/963725 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1544 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814670.pdf [firstpage_image] =>[orig_patent_app_number] => 963725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360164 [patent_doc_number] => 06191169 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states' [patent_app_type] => 1 [patent_app_number] => 8/945744 [patent_app_country] => US [patent_app_date] => 1997-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 38 [patent_no_of_words] => 15016 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191169.pdf [firstpage_image] =>[orig_patent_app_number] => 945744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087099 [patent_doc_number] => 06025396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Stable prostaglandin E1-containing injectable composition' [patent_app_type] => 1 [patent_app_number] => 8/959664 [patent_app_country] => US [patent_app_date] => 1997-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3251 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025396.pdf [firstpage_image] =>[orig_patent_app_number] => 959664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4065970 [patent_doc_number] => 06008221 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Method for treating Alzheimer\'s disease with folic acid' [patent_app_type] => 1 [patent_app_number] => 8/959035 [patent_app_country] => US [patent_app_date] => 1997-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10190 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008221.pdf [firstpage_image] =>[orig_patent_app_number] => 959035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3928433 [patent_doc_number] => 05877216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Treatment of female sexual dysfunction' [patent_app_type] => 1 [patent_app_number] => 8/959064 [patent_app_country] => US [patent_app_date] => 1997-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7486 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877216.pdf [firstpage_image] =>[orig_patent_app_number] => 959064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761116 [patent_doc_number] => 05843919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Composition and method for the treatment of arthritis' [patent_app_type] => 1 [patent_app_number] => 8/955098 [patent_app_country] => US [patent_app_date] => 1997-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4092 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843919.pdf [firstpage_image] =>[orig_patent_app_number] => 955098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4072724 [patent_doc_number] => 06069175 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Estrogen agonist/antagonists treatment of atherosclerosis' [patent_app_type] => 1 [patent_app_number] => 8/955062 [patent_app_country] => US [patent_app_date] => 1997-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4543 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069175.pdf [firstpage_image] =>[orig_patent_app_number] => 955062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225520 [patent_doc_number] => 20020004529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'METHODS, COMPOSITIONS, AND KITS FOR ENHANCING FEMALE SEXUAL DESIRE AND RESPONSIVENESS' [patent_app_type] => new [patent_app_number] => 08/954122 [patent_app_country] => US [patent_app_date] => 1997-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8207 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004529.pdf [firstpage_image] =>[orig_patent_app_number] => 08954122 [rel_patent_id] =>[rel_patent_doc_number] =>)